The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global C1 Esterase Inhibitor Market Research Report 2024
Synopsis
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.
The global C1 Esterase Inhibitor market was valued at US$ 128.6 million in 2023 and is anticipated to reach US$ 194 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
The C1 esterase inhibitor market has experienced substantial growth in recent years. C1 esterase inhibitor is a therapeutic product used for the treatment of hereditary angioedema (HAE), a rare genetic disorder characterized by recurrent episodes of swelling in various body parts, including the face, extremities, and gastrointestinal tract.The market growth can be attributed to several factors. Firstly, increased awareness and improved diagnostic capabilities have led to a better identification of HAE cases, thereby driving the demand for C1 esterase inhibitor therapy. Secondly, advancements in biotechnology and recombinant DNA technology have paved the way for the development of novel and more efficient C1 esterase inhibitor products, offering improved treatment options for patients.
This report aims to provide a comprehensive presentation of the global market for C1 Esterase Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C1 Esterase Inhibitor.
Report Scope
The C1 Esterase Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global C1 Esterase Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the C1 Esterase Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Behring
Takeda
Pharming Intellectual
Segment by Type
Human
Recombinant
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of C1 Esterase Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of C1 Esterase Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.
The global C1 Esterase Inhibitor market was valued at US$ 128.6 million in 2023 and is anticipated to reach US$ 194 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
The C1 esterase inhibitor market has experienced substantial growth in recent years. C1 esterase inhibitor is a therapeutic product used for the treatment of hereditary angioedema (HAE), a rare genetic disorder characterized by recurrent episodes of swelling in various body parts, including the face, extremities, and gastrointestinal tract.The market growth can be attributed to several factors. Firstly, increased awareness and improved diagnostic capabilities have led to a better identification of HAE cases, thereby driving the demand for C1 esterase inhibitor therapy. Secondly, advancements in biotechnology and recombinant DNA technology have paved the way for the development of novel and more efficient C1 esterase inhibitor products, offering improved treatment options for patients.
This report aims to provide a comprehensive presentation of the global market for C1 Esterase Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C1 Esterase Inhibitor.
Report Scope
The C1 Esterase Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global C1 Esterase Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the C1 Esterase Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Behring
Takeda
Pharming Intellectual
Segment by Type
Human
Recombinant
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of C1 Esterase Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of C1 Esterase Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 C1 Esterase Inhibitor Market Overview
1.1 Product Overview and Scope of C1 Esterase Inhibitor
1.2 C1 Esterase Inhibitor Segment by Type
1.2.1 Global C1 Esterase Inhibitor Market Value Comparison by Type (2024-2030)
1.2.2 Human
1.2.3 Recombinant
1.3 C1 Esterase Inhibitor Segment by Application
1.3.1 Global C1 Esterase Inhibitor Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global C1 Esterase Inhibitor Market Size Estimates and Forecasts
1.4.1 Global C1 Esterase Inhibitor Revenue 2019-2030
1.4.2 Global C1 Esterase Inhibitor Sales 2019-2030
1.4.3 Global C1 Esterase Inhibitor Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 C1 Esterase Inhibitor Market Competition by Manufacturers
2.1 Global C1 Esterase Inhibitor Sales Market Share by Manufacturers (2019-2024)
2.2 Global C1 Esterase Inhibitor Revenue Market Share by Manufacturers (2019-2024)
2.3 Global C1 Esterase Inhibitor Average Price by Manufacturers (2019-2024)
2.4 Global C1 Esterase Inhibitor Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of C1 Esterase Inhibitor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of C1 Esterase Inhibitor, Product Type & Application
2.7 C1 Esterase Inhibitor Market Competitive Situation and Trends
2.7.1 C1 Esterase Inhibitor Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest C1 Esterase Inhibitor Players Market Share by Revenue
2.7.3 Global C1 Esterase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 C1 Esterase Inhibitor Retrospective Market Scenario by Region
3.1 Global C1 Esterase Inhibitor Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global C1 Esterase Inhibitor Global C1 Esterase Inhibitor Sales by Region: 2019-2030
3.2.1 Global C1 Esterase Inhibitor Sales by Region: 2019-2024
3.2.2 Global C1 Esterase Inhibitor Sales by Region: 2025-2030
3.3 Global C1 Esterase Inhibitor Global C1 Esterase Inhibitor Revenue by Region: 2019-2030
3.3.1 Global C1 Esterase Inhibitor Revenue by Region: 2019-2024
3.3.2 Global C1 Esterase Inhibitor Revenue by Region: 2025-2030
3.4 North America C1 Esterase Inhibitor Market Facts & Figures by Country
3.4.1 North America C1 Esterase Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America C1 Esterase Inhibitor Sales by Country (2019-2030)
3.4.3 North America C1 Esterase Inhibitor Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe C1 Esterase Inhibitor Market Facts & Figures by Country
3.5.1 Europe C1 Esterase Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe C1 Esterase Inhibitor Sales by Country (2019-2030)
3.5.3 Europe C1 Esterase Inhibitor Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific C1 Esterase Inhibitor Market Facts & Figures by Country
3.6.1 Asia Pacific C1 Esterase Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific C1 Esterase Inhibitor Sales by Country (2019-2030)
3.6.3 Asia Pacific C1 Esterase Inhibitor Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America C1 Esterase Inhibitor Market Facts & Figures by Country
3.7.1 Latin America C1 Esterase Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America C1 Esterase Inhibitor Sales by Country (2019-2030)
3.7.3 Latin America C1 Esterase Inhibitor Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa C1 Esterase Inhibitor Market Facts & Figures by Country
3.8.1 Middle East and Africa C1 Esterase Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa C1 Esterase Inhibitor Sales by Country (2019-2030)
3.8.3 Middle East and Africa C1 Esterase Inhibitor Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global C1 Esterase Inhibitor Sales by Type (2019-2030)
4.1.1 Global C1 Esterase Inhibitor Sales by Type (2019-2024)
4.1.2 Global C1 Esterase Inhibitor Sales by Type (2025-2030)
4.1.3 Global C1 Esterase Inhibitor Sales Market Share by Type (2019-2030)
4.2 Global C1 Esterase Inhibitor Revenue by Type (2019-2030)
4.2.1 Global C1 Esterase Inhibitor Revenue by Type (2019-2024)
4.2.2 Global C1 Esterase Inhibitor Revenue by Type (2025-2030)
4.2.3 Global C1 Esterase Inhibitor Revenue Market Share by Type (2019-2030)
4.3 Global C1 Esterase Inhibitor Price by Type (2019-2030)
5 Segment by Application
5.1 Global C1 Esterase Inhibitor Sales by Application (2019-2030)
5.1.1 Global C1 Esterase Inhibitor Sales by Application (2019-2024)
5.1.2 Global C1 Esterase Inhibitor Sales by Application (2025-2030)
5.1.3 Global C1 Esterase Inhibitor Sales Market Share by Application (2019-2030)
5.2 Global C1 Esterase Inhibitor Revenue by Application (2019-2030)
5.2.1 Global C1 Esterase Inhibitor Revenue by Application (2019-2024)
5.2.2 Global C1 Esterase Inhibitor Revenue by Application (2025-2030)
5.2.3 Global C1 Esterase Inhibitor Revenue Market Share by Application (2019-2030)
5.3 Global C1 Esterase Inhibitor Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Behring C1 Esterase Inhibitor Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Corporation Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Takeda C1 Esterase Inhibitor Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Pharming Intellectual
6.3.1 Pharming Intellectual Corporation Information
6.3.2 Pharming Intellectual Description and Business Overview
6.3.3 Pharming Intellectual C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pharming Intellectual C1 Esterase Inhibitor Product Portfolio
6.3.5 Pharming Intellectual Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 C1 Esterase Inhibitor Industry Chain Analysis
7.2 C1 Esterase Inhibitor Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 C1 Esterase Inhibitor Production Mode & Process
7.4 C1 Esterase Inhibitor Sales and Marketing
7.4.1 C1 Esterase Inhibitor Sales Channels
7.4.2 C1 Esterase Inhibitor Distributors
7.5 C1 Esterase Inhibitor Customers
8 C1 Esterase Inhibitor Market Dynamics
8.1 C1 Esterase Inhibitor Industry Trends
8.2 C1 Esterase Inhibitor Market Drivers
8.3 C1 Esterase Inhibitor Market Challenges
8.4 C1 Esterase Inhibitor Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
